Voyager Therapeutics' anti-tau monoclonal antibody VY7523 demonstrated an excellent safety and PK profile in phase 1 SAD.

United Therapeutics Corporation Strong Buy: phase 3 Tyvaso wins in IPF boost FVC, support summer sNDA and Priority Review ...

Gracenote found that usage of chatbots for a range of purposes is gaining traction across generations, with 66% reporting ...

Video premier in honor of Brigadier General Charles McGee supports “living monument” for the famed Tuskegee Airman and students who pursue STEM degrees at HBCUs ...

SILVER SPRING, MD, UNITED STATES, March 26, 2026 /EINPresswire.com/ — Alpha Phi Alpha Fraternity Incorporated, Iota Upsilon Lambda Chapter in Montgomery County (MD ...

Gracenote, the content intelligence business unit of Nielsen, has examined how AI is changing the ways people find and watch ...